Anavex Life Sciences (AVXL) Change in Taxes (2018 - 2025)
Anavex Life Sciences' (AVXL) quarterly Change in Taxes came in at $35000.0 in Q4 2025, down 67.59% year-on-year from $108000.0 in Q4 2024, and up 418.18% quarter-over-quarter from -$11000.0 in Q3 2025.
Anavex Life Sciences (AVXL) Change in Taxes (2018 - 2025) Analysis & Trends
Anavex Life Sciences has disclosed Change in Taxes across 8 years of filings, most recently posting $35000.0 for Q4 2025.
- Change in Taxes for Q4 2025 came in at $35000.0, down 67.59% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.7 million (down 72.68% YoY), and the FY2025 annual result was -$1.6 million, down 530.77% from the prior year.
- Change in Taxes came in at $35000.0 for Q4 2025 at Anavex Life Sciences, up from -$11000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $1.3 million in Q2 2021 to a low of -$3.8 million in Q4 2021.
- The 5-year median for Change in Taxes is $195000.0 (2024), against an average of -$286723.4.
- Across the five-year window, Change in Taxes soared 310.8% in 2021 and tumbled 2931.29% in 2023, its largest moves.
- Anavex Life Sciences' Change in Taxes stood at -$3.8 million in 2021, then surged by 123.96% to $902000.0 in 2022, then declined by 6.87% to $840000.0 in 2023, then tumbled by 87.14% to $108000.0 in 2024, then plunged by 67.59% to $35000.0 in 2025.
- The last three Change in Taxes figures came in at $35000.0 (Q4 2025), -$11000.0 (Q3 2025), and $154000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Anavex Life Sciences | 221.68 Mn | 89.93 Mn | - | 35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Mar 31, 2025 | -1.89 Mn |
| Mar 31, 2025 | -1.89 Mn |
| Dec 31, 2024 | 108,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Sep 30, 2024 | 729,000.00 |
| Sep 30, 2024 | 729,000.00 |
| Jun 30, 2024 | -2.07 Mn |
| Jun 30, 2024 | -2.07 Mn |
| Mar 31, 2024 | 236,000.00 |
| Mar 31, 2024 | 236,000.00 |
| Dec 31, 2023 | 840,000.00 |
| Dec 31, 2023 | 840,000.00 |
| Sep 30, 2023 | 543,000.00 |
| Sep 30, 2023 | 543,000.00 |